Accordingly, a metabolomic investigation in SH-SY5Y, a Parkinson’s disease model, found that PEMFs changed the metabolome profile and boosted the PI3K/AKT pathway, implying a function for them in autophagy inhibition and dopamine neuron survival [51]. This evidence concerns the gene AKT1 and Parkinson disease.